【how to get a loan for 97000】Here is Why Growth Investors Should Buy Broadcom Inc. (AVGO) Now
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However,how to get a loan for 97000 it isn't easy to find a great growth stock.
By their very nature, these stocks carry above-average risk and volatility. Moreover, if a company's growth story is over or nearing its end, betting on it could lead to significant loss.
However, the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects, makes it pretty easy to find cutting-edge growth stocks.
Broadcom Inc. (AVGO) is on the list of such stocks currently recommended by our proprietary system. In addition to a favorable Growth Score, it carries a top Zacks Rank.
Research shows that stocks carrying the best growth features consistently beat the market. And for stocks that have a combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy) or 2 (Buy), returns are even better.
Here are three of the most important factors that make the stock of this chipmaker a great growth pick right now.
Earnings Growth
Earnings growth is arguably the most important factor, as stocks exhibiting exceptionally surging profit levels tend to attract the attention of most investors. For growth investors, double-digit earnings growth is highly preferable, as it is often perceived as an indication of strong prospects (and stock price gains) for the company under consideration.
While the historical EPS growth rate for Broadcom Inc. is 18.2%, investors should actually focus on the projected growth. The company's EPS is expected to grow 18.4% this year, crushing the industry average, which calls for EPS growth of 16.8%.
Cash Flow Growth
Cash is the lifeblood of any business, but higher-than-average cash flow growth is more beneficial and important for growth-oriented companies than for mature companies. That's because, high cash accumulation enables these companies to undertake new projects without raising expensive outside funds.
Right now, year-over-year cash flow growth for Broadcom Inc. is 13.5%, which is higher than many of its peers. In fact, the rate compares to the industry average of -0.9%.
While investors should actually consider the current cash flow growth, it's worth taking a look at the historical rate too for putting the current reading into proper perspective. The company's annualized cash flow growth rate has been 35.3% over the past 3-5 years versus the industry average of 9.6%.
Story continues
Promising Earnings Estimate Revisions
Superiority of a stock in terms of the metrics outlined above can be further validated by looking at the trend in earnings estimate revisions. A positive trend is of course favorable here. Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
The current-year earnings estimates for Broadcom Inc. have been revising upward. The Zacks Consensus Estimate for the current year has surged 5.2% over the past month.
Bottom Line
While the overall earnings estimate revisions have made Broadcom Inc. a Zacks Rank #2 stock, it has earned itself a Growth Score of B based on a number of factors, including the ones discussed above.
You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
This combination positions Broadcom Inc. well for outperformance, so growth investors may want to bet on it.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report
Broadcom Inc. (AVGO) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
View comments
下一篇:EXPLAINER-Why is Israel holding its third election in a year?
相关文章:
- ESSA Bank & Trust Forms Relationship with Ameriprise Financial to Expand Financial Planning and Investment Services
- Ethics Forum: Questions and Answers on Professional Responsibility
- Toronto Blue Jays Announcer Fired For “Inappropriate Behavior” With Women
- How Much Of Rajvir Industries Limited (NSE:RAJVIR) Do Insiders Own?
- Hedge Funds Aren’t Done Buying Euronav NV (EURN)
- Infighting Between Lanier and Objectors Over Fees Roils Hip Implant Litigation
- University of Michigan Consumer Sentiment Index Remains Near Two-Year Lows
- Trump trade war taking toll on China’s economy?
- Number of voting rights as of November 30,2020
- Just 3 Days Before Class Limited (ASX:CL1) Will Be Trading Ex-Dividend
相关推荐:
- Aptose to Hold Corporate Update Sunday, December 6th
- Evaluating TIL Enviro Limited’s (HKG:1790) Investments In Its Business
- BRIEF-Xinjiang Machinery Research Institute's Unit Clinches Orders Worth About 192 Mln Yuan
- Can Valero Energy (VLO) Keep the Earnings Surprise Streak Alive?
- Galleon Gold Acquires Additional Interest in the Neal Gold Project and Increases Previously Announced Private Placement
- China is Bullish on Cryptocurrencies
- Aurobindo Pharma to recall 80 lots of blood pressure medicine valsartan in U.S.
- BRIEF-India Cuts Import Tax On Palm Oil Sourced From ASEAN Countries - Govt Notification
- Bitcoin Sees Record Number of Active Users as Price Almost Hits $20K
- How Does China Maple Leaf Educational Systems Limited (HKG:1317) Affect Your Portfolio Volatility?
- Domino's (DPZ) Opens 17,000th Store, Expands in Australia
- Thai Airways rescue plan is its last chance, says PM
- Global Hospital Beds Market Report 2020: Market to Reach $5.2 Billion by 2027
- ROSEN, A RESPECTED AND LEADING FIRM, Encourages GSX Techedu Inc. Investors to Contact Firm Before Deadline in Class Action Seeking Recovery of Investor Losses – GSX
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Spirit AeroSystems Holdings, Inc. - SPR
- Eversource (ES) Q3 Earnings Lag, Revenues Beat Estimates
- Glenbriar Announces Agreement to Acquire Kick Pharmaceuticals Inc.
- Outlook into the Worldwide Plasma Protein Therapeutics to 2025 - Featuring CSL Behring, Biotest AG & Baxter Among Others
- Ramping up COVID-19 testing earlier would have helped the UK, top adviser says
- Outlook into the Worldwide Plasma Protein Therapeutics to 2025 - Featuring CSL Behring, Biotest AG & Baxter Among Others
- https://telegra.ph/Thyssenkrupp-sees-coronavirus-cash-squeeze-despite-elevator-sale---letter-10-01
- https://telegra.ph/Crypto-Wallet-Abra-Opens-Door-to-More-European-Users-10-01
- https://telegra.ph/Taking-Down-Trump-Documentarians-Profile-Courageous-Local-Voices-10-01
- https://telegra.ph/The-best-city-for-small-business-in-America-is-not-in-Silicon-Valley-10-01
- https://telegra.ph/Where-CEWE-Stiftung--Co-KGaAs-ETRCWC-Earnings-Growth-Stands-Against-Its-Industry-10-01
- https://telegra.ph/Boris-Johnson-Needs-a-Major-Lesson-in-Empathy-10-01
- https://telegra.ph/Harry-Potter-Fans-Try-to-Free-Dobby-Statue-With-Socks-10-01
- https://telegra.ph/The-global-aircraft-interface-device-market-size-is-projected-to-grow-from-USD-167-million-in-2020-to-USD-311-million-by-2025-at-10-01
- https://telegra.ph/Harold-Perrineau-Welcomes-Daughter-Holiday-Grace-10-01
- https://telegra.ph/Watch-Jimmy-Fallon-Lead-a-Star-Studded-Sing-Along-to-Paul-McCartneys-Wonderful-Christmastime-10-01